글번호
241486
작성일
2021.09.18
수정일
2021.09.18
작성자
김민걸
조회수
21

Comparison of the Pharmacokinetics, Safety, and Tolerability of Vitamin D3 in DP-R206 (150-mg Ibandronate/24,000-IU Vitamin D3 Tablet) and as Monotherapy (24,000 IU) in Healthy Male Korean Adults

Comparison of the Pharmacokinetics, Safety, and Tolerability of Vitamin D3 in DP-R206 (150-mg Ibandronate/24,000-IU Vitamin D3 Tablet) and as Monotherapy (24,000 IU) in Healthy Male Korean Adults
Title
Comparison of the Pharmacokinetics, Safety, and Tolerability of Vitamin D3 in DP-R206 (150-mg Ibandronate/24,000-IU Vitamin D3 Tablet) and as Monotherapy (24,000 IU) in Healthy Male Korean Adults
Author
Ji-Young Jeon, Sun Young Lee, Yong-Jin Im, Eun-Young Kim, Yunjeong Kim, Tae Sun Park, Soo-Wan Chae, Jae Won Lee, Hun Jun, Tae Won Lee, Min-Gul Kim
Year
2014
Journal
Clin Ther
Details
2014 Jan 1;36(1):48-57
DOI
10.1016/j.clinthera.2013.12.001
첨부파일
첨부파일이(가) 없습니다.
다음글
Pharmacokinetic Characteristics of Ibandronate and Tolerability of DP-R206 (150 mg Ibandronate/24,000 IU Vitamin D3) Compared to the Ibandronate (150 mg) Monotherapy in Healthy Adults
김민걸 2021-09-18 23:34:28.0
이전글
Pharmacokinetic comparisons between two formulations containing 100 mg of miglitol in healthy Korean male volunteers: A randomized, open-label, single-dose, two-period, twosequence crossover bioequivalence study
김민걸 2021-09-18 23:34:08.0